+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Lipid Nanoparticle Formulation & Development Services Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2026
  • Region: Global
  • Grand View Research
  • ID: 6292327
The global lipid nanoparticle formulation & development services market size was valued at USD 410.0 million in 2025 and is projected to grow from USD 447.8 million in 2026 to USD 918.8 million by 2033, at a CAGR of 10.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 43.6% in 2025. The market growth is driven by increasing demand for advanced drug delivery systems, growing adoption of mRNA-based therapeutics and vaccines, rising investments in nanomedicine, and expanding applications of lipid nanoparticles in gene therapy, oncology, and drug development.

Market Concentration & Characteristics

The degree of innovation in the lipid nanoparticle formulation & development services industry is high, driven by advances in artificial intelligence-assisted lipid discovery, high-throughput screening, microfluidic formulation, and targeted LNP design. For instance, in July 2024, researchers reported the AI-Guided Ionizable Lipid Engineering (AGILE) platform, which combines deep learning with combinatorial chemistry to accelerate the design and screening of ionizable lipids for mRNA delivery. The platform enables rapid identification of cell-specific lipid candidates, improving formulation development efficiency and supporting more targeted and effective LNP-based delivery.
The lipid nanoparticle formulation & development services industry is witnessing moderate M&A activity, as companies seek to expand specialized formulation and CDMO capabilities. For instance, in September 2024, Agilent Technologies completed its acquisition of BIOVECTRA for approximately USD 925 million, adding BIOVECTRA’s lipid nanoparticle (LNP) formulation, pDNA, and mRNA capabilities to its CDMO portfolio. The acquisition strengthens Agilent’s end-to-end biopharmaceutical development and manufacturing services and expands access to specialized LNP formulation capabilities.

“We are delighted to officially welcome the BIOVECTRA team to Agilent. This acquisition demonstrates our commitment to providing customers the most advanced capabilities to accelerate their therapeutics programs, including best-in-class cGMP pharmaceutical manufacturing.”
  • Padraig McDonnell, Agilent President and CEO.
The impact of regulations on the lipid nanoparticle formulation and development services market is high, as regulatory requirements increasingly emphasize the characterization and control of critical quality attributes of LNP-based products. For instance, in March 2025, the European Medicines Agency (EMA) published a draft guideline on the quality of mRNA vaccines specifying quality considerations for LNPs, including lipid identity and content, particle size, polydispersity, mRNA encapsulation efficiency, and lipid-related impurities. These requirements increase demand for specialized LNP formulation, analytical characterization, process development, and quality-control services.

The lipid nanoparticle formulation and development services market is witnessing product expansion through the introduction of integrated LNP development and manufacturing services. For instance, in March 2025, Biomay announced GMP services for lipid-based nanoparticles, expanding its platform to include LNP formulation, process development, analytical assay development, characterization, release testing, and aseptic filling. The expanded offering provides an integrated pathway from mRNA production through LNP formulation and filling, supporting the development and manufacturing of RNA-based therapeutics.

The lipid nanoparticle formulation and development services market is witnessing regional expansion as specialized CDMOs increase LNP formulation and manufacturing capacity in key biopharmaceutical markets. For instance, in August 2026, Evonik announced a new GMP manufacturing facility in Vancouver, Canada, to expand its lipid-based drug delivery capabilities, including LNP development and clinical drug product manufacturing. The investment is expected to more than triple manufacturing capacity and strengthen Evonik’s regional presence and global LNP formulation and manufacturing network, supporting growing demand for specialized development services.

“Lipid-based drug delivery technologies are already enabling the next generation of medicines. With the support of the Canadian federal government, this investment builds on our long-standing expertise in the field, enabling the development and commercialization of more life-changing therapies”
  • Lauren Kjeldsen, member of Evonik’s Executive Board and COO for the Custom Solutions segment at Evonik.

Global Lipid Nanoparticle Formulation & Development Services Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global lipid nanoparticle formulation & development services market report based on service, payload type, scale of operation, end user, and region:

Service Outlook (Revenue, USD Million, 2021 - 2033)

  • LNP Formulation Development
  • Analytical Development & Characterization
  • Process Development & Scale-Up
  • CMC & Technology Transfer Support
  • Others (Clinical/GMP Formulation Development, etc.)

Payload Type Outlook (Revenue, USD Million, 2021 - 2033)

  • mRNA
  • siRNA
  • saRNA
  • Gene-Editing Payloads
  • Other (Plasmid DNA/DNA, etc.)

Scale of Operation Outlook (Revenue, USD Million, 2021 - 2033)

  • Preclinical
  • Clinical
  • Commercial

End User Outlook (Revenue, USD Million, 2021 - 2033)

  • Biopharmaceutical Companies
  • Academic & Research Institutions
  • Government / Public Research Organizations

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Service Segment
1.1.1.2. Payload Type Segment
1.1.1.3. Scale of Operation Segment
1.1.1.4. End User Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. The internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. List of Secondary Sources
1.9.3. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Outsourcing of LNP Formulation and Development Services
3.2.1.2. Rising Development of mRNA and Nucleic Acid-Based Therapeutics
3.2.1.3. Growing Demand for Advanced LNP Delivery Systems for Extrahepatic Applications
3.2.2. Market Restraint Analysis
3.2.2.1. Complex Formulation Optimization and Stability Requirements
3.2.2.2. Limited Scalability of LNP Formulation Processes from Development to Commercial Manufacturing
3.2.3. Market Opportunities Analysis
3.2.4. Market Challenges Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Social landscape
3.3.2.4. Economic landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape
Chapter 4. Service Business Analysis
4.1. Segment Dashboard
4.2. Lipid Nanoparticle Formulation & Development Services Market: Service Movement Analysis
4.3. LNP Formulation Development
4.3.1. LNP Formulation Development Market, 2021 - 2033 (USD Million)
4.4. Analytical Development & Characterization
4.4.1. Analytical Development & Characterization Market, 2021 - 2033 (USD Million)
4.5. Process Development & Scale-Up
4.5.1. Process Development & Scale-Up Market, 2021 - 2033 (USD Million)
4.6. CMC & Technology Transfer Support
4.6.1. CMC & Technology Transfer Support Market, 2021 - 2033 (USD Million)
4.7. Others (Clinical/GMP Formulation Development, etc.)
4.7.1. Others (Clinical/GMP Formulation Development, etc.) Market, 2021 - 2033 (USD Million)
Chapter 5. Payload Type Business Analysis
5.1. Segment Dashboard
5.2. Lipid Nanoparticle Formulation & Development Services Market: Payload Type Movement Analysis
5.3. mRNA
5.3.1. mRNA Market, 2021 - 2033 (USD Million)
5.4. siRNA
5.4.1. siRNA Market, 2021 - 2033 (USD Million)
5.5. saRNA
5.5.1. saRNA Market, 2021 - 2033 (USD Million)
5.6. Gene-Editing Payloads
5.6.1. Gene-Editing Payloads Market, 2021 - 2033 (USD Million)
5.7. Other (Plasmid DNA/DNA, etc.)
5.7.1. Other (Plasmid DNA/DNA, etc.) Market, 2021 - 2033 (USD Million)
Chapter 6. Scale of Operation Business Analysis
6.1. Segment Dashboard
6.2. Lipid Nanoparticle Formulation & Development Services Market: Scale of Operation Movement Analysis
6.3. Preclinical
6.3.1. Preclinical Market, 2021 - 2033 (USD Million)
6.4. Clinical
6.4.1. Clinical Market, 2021 - 2033 (USD Million)
6.5. Commercial
6.5.1. Commercial Market, 2021 - 2033 (USD Million)
Chapter 7. End User Business Analysis
7.1. Segment Dashboard
7.2. Lipid Nanoparticle Formulation & Development Services Market: End User Movement Analysis
7.3. Biopharmaceutical Companies
7.3.1. Biopharmaceutical Companies Market, 2021 - 2033 (USD Million)
7.4. Academic & Research Institutions
7.4.1. Academic & Research Institutions Market, 2021 - 2033 (USD Million)
7.5. Government/Public Research Organizations
7.5.1. Government/Public Research Organizations Market, 2021 - 2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Lipid Nanoparticle Formulation & Development Services Market Share by Region, 2025 & 2033
8.2. North America
8.2.1. North America Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. U.S. Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Canada Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Framework
8.2.4.4. Mexico Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.3. Europe
8.3.1. Europe Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. UK Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Germany Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. France Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Italy Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Spain Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Denmark Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Sweden Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Norway Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Japan Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. China Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. India Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Australia Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Thailand Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. South Korea Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.5. Latin America
8.5.1. Latin America Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Brazil Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Argentina Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.6. MEA
8.6.1. MEA Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. South Africa Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Saudi Arabia Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. UAE Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Kuwait Lipid Nanoparticle Formulation & Development Services Market, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Company Market Share/ Position Analysis, 2025
9.3. Strategy Mapping
9.4. Company Profiles/Listing
9.4.1. Lonza
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Type Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Evonik Industries AG
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Type Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. CordenPharma (acquired by Astorg)
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Type Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Thermo Fisher Scientific Inc.
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Type Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. WuXi STA (WuXi AppTec)
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Type Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. FUJIFILM Biotechnologies
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Type Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Polymun Scientific Immunbiologische Forschung GmbH
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Type Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Curia Global, Inc.
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Type Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Merck KGaA
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Type Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Phosphorex
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Type Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Curapath
9.4.11.1. Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Type Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. Creative Biolabs
9.4.12.1. Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Type Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. Etherna
9.4.13.1. Overview
9.4.13.2. Financial Performance
9.4.13.3. Product Type Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. NanoVation
9.4.14.1. Overview
9.4.14.2. Financial Performance
9.4.14.3. Product Type Benchmarking
9.4.14.4. Strategic Initiatives
9.4.15. AGC-Biologics
9.4.15.1. Overview
9.4.15.2. Financial Performance
9.4.15.3. Product Type Benchmarking
9.4.15.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 4 Global lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 5 Global lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 6 Global lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 7 Global lipid nanoparticle formulation & development services market, region, 2021 - 2033 (USD Million)
Table 8 North America lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Table 9 North America lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 10 North America lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 11 North America lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 12 North America lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 13 U.S. lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 14 U.S. lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 15 U.S. lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 16 U.S. lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 17 Canada lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 18 Canada lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 19 Canada lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 20 Canada lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 21 Mexico lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 22 Mexico lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 23 Mexico lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 24 Mexico lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 25 Europe lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Table 26 Europe lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 27 Europe lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 28 Europe lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 29 Europe lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 30 UK lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 31 UK lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 32 UK lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 33 UK lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 34 Germany lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 35 Germany lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 36 Germany lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 37 Germany lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 38 France lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 39 France lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 40 France lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 41 France lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 42 Italy lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 43 Italy lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 44 Italy lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 45 Italy lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 46 Spain lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 47 Spain lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 48 Spain lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 49 Spain lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 50 Denmark lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 51 Denmark lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 52 Denmark lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 53 Denmark lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 54 Sweden lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 55 Sweden lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 56 Sweden lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 57 Sweden lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 58 Norway lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 59 Norway lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 60 Norway lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 61 Norway lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 62 Asia Pacific lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 64 Asia Pacific lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 65 Asia Pacific lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 66 Asia Pacific lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 67 Japan lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 68 Japan lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 69 Japan lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 70 Japan lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 71 China lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 72 China lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 73 China lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 74 China lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 75 India lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 76 India lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 77 India lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 78 India lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 79 Australia lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 80 Australia lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 81 Australia lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 82 Australia lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 83 Thailand lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 84 Thailand lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 85 Thailand lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 86 Thailand lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 87 South Korea lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 88 South Korea lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 89 South Korea lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 90 South Korea lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 91 Latin America lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Table 92 Latin America lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 93 Latin America lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 94 Latin America lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 95 Latin America lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 96 Brazil lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 97 Brazil lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 98 Brazil lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 99 Brazil lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 100 Argentina lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 101 Argentina lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 102 Argentina lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 103 Argentina lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 104 Middle East & Africa lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Table 105 Middle East & Africa lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 106 Middle East & Africa lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 107 Middle East & Africa lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 108 Middle East & Africa lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 109 South Africa lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 110 South Africa lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 111 South Africa lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 112 South Africa lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 116 Saudi Arabia lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 117 UAE lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 118 UAE lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 119 UAE lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 120 UAE lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
Table 121 Kuwait lipid nanoparticle formulation & development services market, service, 2021 - 2033 (USD Million)
Table 122 Kuwait lipid nanoparticle formulation & development services market, payload type, 2021 - 2033 (USD Million)
Table 123 Kuwait lipid nanoparticle formulation & development services market, scale of operation, 2021 - 2033 (USD Million)
Table 124 Kuwait lipid nanoparticle formulation & development services market, end user, 2021 - 2033 (USD Million)
List of Figures
Figure 1 Lipid nanoparticle formulation & development services market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Parent market outlook
Figure 11 Lipid nanoparticle formulation & development services market driver analysis
Figure 12 Lipid nanoparticle formulation & development services market restraint analysis
Figure 13 Lipid nanoparticle formulation & development services market: Porter's five forces analysis
Figure 14 Lipid nanoparticle formulation & development services market: PESTLE analysis
Figure 15 Lipid nanoparticle formulation & development services market: Service outlook and key takeaways
Figure 16 Lipid nanoparticle formulation & development services market: Service market share analysis
Figure 17 LNP formulation development market, 2021 - 2033 (USD Million)
Figure 18 Analytical development & characterization market, 2021 - 2033 (USD Million)
Figure 19 Process development & scale-up market, 2021 - 2033 (USD Million)
Figure 20 CMC & technology transfer support market, 2021 - 2033 (USD Million)
Figure 21 Others (clinical/GMP formulation development, etc.) market, 2021 - 2033 (USD Million)
Figure 22 Lipid nanoparticle formulation & development services market: Payload type outlook and key takeaways
Figure 23 Lipid nanoparticle formulation & development services market: Payload type market share analysis
Figure 24 mRNA market, 2021 - 2033 (USD Million)
Figure 25 siRNA market, 2021 - 2033 (USD Million)
Figure 26 saRNA market, 2021 - 2033 (USD Million)
Figure 27 Gene-editing payloads market, 2021 - 2033 (USD Million)
Figure 28 Other (plasmid DNA/DNA, etc.) market, 2021 - 2033 (USD Million)
Figure 29 Lipid nanoparticle formulation & development services market: Scale of operation outlook and key takeaways
Figure 30 Lipid nanoparticle formulation & development services market: Scale of operation market share analysis
Figure 31 Preclinical market, 2021 - 2033 (USD Million)
Figure 32 Clinical market, 2021 - 2033 (USD Million)
Figure 33 Commercial market, 2021 - 2033 (USD Million)
Figure 34 Lipid nanoparticle formulation & development services market: End user outlook and key takeaways
Figure 35 Lipid nanoparticle formulation & development services market: End user market share analysis
Figure 36 Biopharmaceutical companies market, 2021 - 2033 (USD Million)
Figure 37 Academic & research institutions market, 2021 - 2033 (USD Million)
Figure 38 Government/public research organizations market, 2021 - 2033 (USD Million)
Figure 39 Regional marketplace: Key takeaways
Figure 40 North America lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Figure 41 U.S. lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 42 Canada lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 43 Mexico lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 44 Europe lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Figure 45 UK lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 46 Germany lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 47 France lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 48 Italy lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 49 Spain lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 50 Denmark lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 51 Sweden lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 52 Norway lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 53 Asia Pacific lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Figure 54 Japan lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 55 China lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 56 India lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 57 Australia lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 58 Thailand lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 59 South Korea lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 60 Latin America lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Figure 61 Brazil lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 62 Argentina lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 63 MEA lipid nanoparticle formulation & development services market, country, 2021 - 2033 (USD Million)
Figure 64 South Africa lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 65 Saudi Arabia lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 66 UAE lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)
Figure 67 Kuwait lipid nanoparticle formulation & development services market, 2021 - 2033 (USD Million)

Companies Mentioned

  • Lonza
  • Evonik Industries AG
  • CordenPharma (acquired by Astorg)
  • Thermo Fisher Scientific Inc.
  • WuXi STA (WuXi AppTec)
  • FUJIFILM Biotechnologies
  • Polymun Scientific Immunbiologische Forschung GmbH
  • Curia Global, Inc.
  • Merck KGaA
  • Phosphorex
  • Curapath
  • Creative Biolabs
  • Etherna
  • NanoVation
  • AGC-Biologics